The Readout Loud cover image

358: FDA's gene therapy turmoil, and an alternative model for funding research

The Readout Loud

00:00

FDA Leadership Shifts and Gene Therapy Challenges

This chapter explores the recent upheaval at the FDA, focusing on the departure of key personnel and its impact on cell and gene therapy regulation. It discusses the tensions between expedited drug approvals, scientific integrity, and the introduction of a new pilot program for faster reviews amid concerns of political influence.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app